Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer

Journal of Pathology 211 巻 4 号 431-438 頁 2007-01 発行
アクセス数 : 583
ダウンロード数 : 222

今月のアクセス数 : 1
今月のダウンロード数 : 2
ファイル情報(添付)
JPathol_211_431.pdf 1020 KB 種類 : 全文
タイトル ( eng )
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer
作成者
Chen Yuan
Ye Fei
Pacyana-Gengelbach Manuela
Knösel Thomas
Deutschmann Nicole
Lund Per
Yasumoto Hiroaki
Petersen Iver
収録物名
Journal of Pathology
211
4
開始ページ 431
終了ページ 438
抄録
Insulin-like growth binding protein-related protein 1 (IGFBP-rP1) has decreased expression in various tumors, but the role of IGFBP-rP1 in lung cancer has not yet been elucidated. In this study, we evaluated the IGFBP-rP1 expression in lung cancer cell lines and we found a reduced expression of IGFBP-rP1 at both mRNA and protein levels. In a tissue microarray containing 138 primary tumors analyzed by immunohistochemistry, 58 cases (42%) exhibited no expression of IGFBP-rP1, additionally, an association between IGFBP-rP1 expression and tumor gradings was found in squamous cell lung cancer. Neither deletion or gene rearrangement nor loss of heterozigosity was responsible for the inactivation of IGFBP-rP1. However, 5-aza-2'-deoxycytidine treatment restored the expression of IGFBP-rP1 in 3 out of 4 lung cancer cell lines. Sequencing of sodium bisulfite?treated genomic DNA from these 3 lung cancer cell lines revealed a heterogeneous methylation pattern in the region of exon 1 and intron 1. Stable transfection of IGFBP-rP1 full-length cDNA into a lung cancer cell line H2170 led to an increased protein expression of IGFBP-rP1. IGFBP-rP1 positive transfectants remarkably reduced the ability of colony formation in soft agar, suppressed the tumor growth rate in nude mice and increased the number of apoptotic cells as well as the expression level of casepase-3 compared to controls. Moreover, treatment with differentiation modulating agent 5-bromodeoxyuridine (BrdU) led to an enhanced expression of IGFBP-rP1 in lung cancer cells. Out data suggest that IGFBP-rP1 is a tumor suppressor possibly via DNA methylation and induction of apoptosis in human lung cancer.
著者キーワード
IGFBP-rP1
human lung cancer
DNA methylation
stable transfection
tumour suppressor
NDC分類
医学 [ 490 ]
言語
英語
資源タイプ 学術雑誌論文
出版者
John Wiley & Sons, Ltd.
発行日 2007-01
権利情報
Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
出版タイプ Author’s Original(十分な品質であるとして、著者から正式な査読に提出される版)
アクセス権 オープンアクセス
収録物識別子
[ISSN] 0022-3417
[DOI] 10.1002/path.2132
[NCID] AA00704326
[PMID] 17236181
[DOI] http://dx.doi.org/10.1002/path.2132 ~の異版である